The Targeted Revolution: Monoclonal Antibodies and JAK Inhibitors
The therapeutic landscape for Canine Atopic Dermatitis has been revolutionized by highly targeted pharmaceuticals that offer rapid and specific relief from itch and inflammation. The introduction of the Janus Kinase (JAK) inhibitor class, like oclacitinib (Apoquel), marked a major step forward. This oral medication works by selectively blocking the action of specific cytokines (signaling...
0 ความคิดเห็น 0 แชร์ 934 ยอดวิว 0 รีวิว